Entera Bio (ENTX) Shares Outstanding (2017 - 2026)
Entera Bio's (ENTX) quarterly Shares Outstanding (Entity) came in at $46.6 million in Q1 2026, up 2.65% YoY from $45.4 million in Q1 2025, and up 0.96% on a QoQ basis from $46.2 million in Q4 2025.
Entera Bio (ENTX) Shares Outstanding (2017 - 2026) Analysis & Trends
Entera Bio (ENTX) has 10 years of Shares Outstanding (Entity) data on file, last reported at $46.6 million in Q1 2026.
- Quarterly Shares Outstanding (Entity) rose 2.65% year-over-year to $46.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $46.6 million (up 2.65% YoY) and the FY2025 annual result came in at $46.2 million, up 18.9% from the prior year.
- Shares Outstanding (Entity) climbed to $46.6 million in Q1 2026, from $46.2 million in the prior quarter.
- In the past five years, Shares Outstanding (Entity) ranged from a high of $46.6 million in Q1 2026 to a low of $28.8 million in Q1 2022.
- A 5-year average of $35.7 million and a median of $35.5 million in 2024 frame the typical range for Shares Outstanding (Entity).
- Annual changes were most pronounced in 2023 — Shares Outstanding (Entity) climbed 0.01% — and 2024, when it soared 33.89%.
- Tracing ENTX's Shares Outstanding (Entity) over 5 years: stood at $28.8 million in 2022, then climbed by 0.69% to $29.0 million in 2023, then jumped by 33.89% to $38.8 million in 2024, then advanced by 18.9% to $46.2 million in 2025, then gained by 0.96% to $46.6 million in 2026.
- The last three Shares Outstanding (Entity) figures came in at $46.6 million (Q1 2026), $46.2 million (Q4 2025), and $45.7 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 253.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 62.19 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 398.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 111.58 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 133.61 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 241.70 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 217.35 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 445.06 Mn |
| 10 | Entera Bio | 161.44 Mn | 150.13 Mn | - | 50.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 50.45 Mn |
| Mar 31, 2026 | 47.76 Mn |
| Dec 31, 2025 | 46.19 Mn |
| Sep 30, 2025 | 47.09 Mn |
| Jun 30, 2025 | 46.84 Mn |
| Mar 31, 2025 | 43.38 Mn |
| Dec 31, 2024 | 37.65 Mn |
| Sep 30, 2024 | 37.64 Mn |
| Jun 30, 2024 | 37.09 Mn |
| Mar 31, 2024 | 36.74 Mn |
| Dec 31, 2023 | 29.01 Mn |
| Sep 30, 2023 | 28.81 Mn |
| Jun 30, 2023 | 28.81 Mn |
| Mar 31, 2023 | 28.81 Mn |
| Dec 31, 2022 | 28.81 Mn |
| Sep 30, 2022 | 28.81 Mn |
| Jun 30, 2022 | 28.81 Mn |
| Mar 31, 2022 | 28.80 Mn |
| Dec 31, 2021 | 26.13 Mn |
| Sep 30, 2021 | 28.68 Mn |